Skip to content
healthcare.dev

Carbidopa and Levodopa

NDC 16571-159, carbidopa and levodopa, tablet, orally disintegrating, from Rising Pharma Holdings, Inc..

Product NDC
16571-159
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078893
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-159 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBIDOPA25 mg/1
  • LEVODOPA250 mg/1

Pharmacologic classes

Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]

Package NDCNDC-11Package
16571-159-0116571015901100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (16571-159-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/302bfe03-d222-4a87-80ff-f2dbfb9a07f4
  • NADAC price for package 16571015901

    GET /v1/drugs/nadac/16571015901

Use it

Look up 16571-159 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-159 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-159. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.